Macquarie Group
RLAY icon

Macquarie Group’s Relay Therapeutics RLAY Stock Holding History

Macquarie Group’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-543
Closed -$11.9K – 2329
2022
Q2 		$9K Hold
543
– – ﹤0.01% 2463
2022
Q1 		$16 Hold
543
– – ﹤0.01% 2439
2021
Q4 		$17K Hold
543
– – ﹤0.01% 2435
2021
Q3 		$17K Hold
543
– – ﹤0.01% 2480
2021
Q2 		$20K Hold
543
– – ﹤0.01% 2363
2021
Q1 		$19K Sell
543
-257
-32% -$11.2K ﹤0.01% 2302
2020
Q4 		$33K Buy
+800
New +$36.2K ﹤0.01% 2130

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Macquarie Group's RLAY Position: Q3 2022 in Review

Macquarie Group sold out of Relay Therapeutics (RLAY) in Q3 2022, closing a stake of 543 shares — an estimated $11.9K sold.

Macquarie Group first reported a position in RLAY in Q4 2020 and held it in 7 quarters. The position peaked at $33K in Q4 2020. 161 funds tracked by Wall St. Rank hold RLAY as of Q3 2022.

  • Macquarie Group reported no remaining Relay Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Macquarie Group sold 543 Relay Therapeutics shares in Q3 2022, an estimated $11.9K.
  • Macquarie Group first reported a position in Relay Therapeutics in Q4 2020 and held it in 7 quarters.
  • Macquarie Group's Relay Therapeutics position peaked at $33K in Q4 2020.
  • 161 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2022.

Based on Macquarie Group's 13F filing for Q3 2022, filed 14 Nov 2022.